Spots Global Cancer Trial Database for Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer
Official Title: A Randomized Study of Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer
Study ID: NCT01794403
Conditions
Study Description
Brief Summary: Accelerated Hypofractionation Radiotherapy for prostate cancer of 36.25 Gy delivered in 5 fractions will not be inferior to the standard treatment of 70.2 Gy given in 26 fractions with respect to two-year failure defined as a positive biopsy two years post treatment completion or earlier evidence of biochemical or clinical failure.
Detailed Description:
Eligibility
Minimum Age: 35 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
University of Miami, Miami, Florida, United States
Northern Sydney Local Health District - Royal North Shore Hospital, St. Leonards, New South Wales, Australia
A.O.U. Città della Salute e della Scienza di Torino - University Hospital Trust of Turin, Turin, , Italy
Contact Details
Name: Matthew Abramowitz, MD
Affiliation: University of Miami
Role: PRINCIPAL_INVESTIGATOR
Name: Alan Pollack, MD, PhD
Affiliation: University of Miami
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
